Vitamin c and iron join fight against deadly brain tumors
NCT ID NCT04900792
First seen Nov 06, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This early-stage study tests whether adding high-dose vitamin C and a special iron drug (ferumoxytol) to standard radiation and chemotherapy can help adults with a newly diagnosed aggressive brain tumor called glioblastoma. The main goal is to find a safe dose of the iron drug. The study involves 17 participants and will also track how long they live without the cancer growing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Radiation Oncology at University of Iowa
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.